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ABSTRACT
Pore-forming toxins secreted by various evolutionarily distant organisms are
important components of their innate defense mechanisms. These toxins may kill the
target cells by inserting un-regulated channels into the plasma membrane. Tampering
with the otherwise well-controlled membrane permeability alters cell homeostasis by
contributing to un-controlled dissipation of both chemical and electrical gradients, which
is often an essential component of virulence mechanisms leading to cell death. However,
the same ability to create nanoscopic conducting pathways, i.e. nanopores, has been
exploited for creating powerful tools in nano-biotechnology. Single nano-channels
reconstituted in artificial planar lipid membranes are extremely versatile sensors that are
capable of detection, identification, and characterization of single molecules. In addition,
the changes in permeability induced by pore-forming toxins reconstituted in artificial and
natural lipid membrane systems are exploited for numerous biomedical, scientific, and
bio-technological applications. Many of these applications, underlying principles, and
limitations are briefly described in the introduction section of this dissertation.
To overcome many of the restrictions presented by currently used pore-forming
toxins, we propose to use lysenin channels for both stochastic sensing and for the
achievement of controlled membrane permeability. Lysenin is a pore-forming toxin
extracted from the earthworm E. foetida that inserts large nanopores in natural and
artificial lipid membranes containing sphingomyelin. Chapter 2 of the presented work is
focused on exploring the use of single lysenin nanopores for stochastic sensing of human
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angiotensin II, a short hormone peptide,which is highly relevant for the pathophysiology
of cardiovascular diseases. Besides a traditional analysis of the interactions between
lysenin channels and peptides, we succeeded to employ high sensitivity liquid
chromatography – mass spectroscopy analyses to demonstrate the passage of un-altered
peptide molecules through open lysenin channels.
In Chapter 3 we exploit the unique regulatory mechanisms presented by lysenin
channels to achieve controlled permeability over artificial and natural lipid membranes.
We demonstrate that ATP molecules may reversibly regulate the macroscopic ionic
conductance of lysenin channels inserted into planar lipid membranes. Lysenin
reconstitution into spherical membranes (liposomes) enables a two-way control over
membrane permeability by using multivalent metal cations capable of inducing reversible
ligand-induced gating of the channels. Live cell analyses demonstrate that lysenin
channels allow transport of non-permeant molecules in Jurkat leukemia and ATDC5
chondrogenic cells. In addition, extended control over membrane permeability is
achieved by using chitosan molecules as irreversible blockers of the macroscopic
conductance. Survival rate estimations indicate that the permeabilized cells maintain a
satisfactory viability rate for further use. Therefore lysenin may be used for the controlled
transport of ions and molecules in living systems.
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CHAPTER ONE: BIOLOGICAL NANOPORES AND THEIR APPLICATIONS FOR
SENSING AND CONTROLLED TRANSPORT
Introduction and Background
Protein channels
Protein channels are ubiquitous transmembrane elements capable of transporting
ions and molecules across artificial and natural lipid membranes [1-6]. Their ability to
overcome the barrier function of the membrane stems from the establishment of tiny
conducting pathways between the aqueous solutions bathing the two sides of the
membrane. Protein channels are essential for cellular activities, including creating and
maintaining electrochemical gradients, producing energy, and enabling communication
[1-6]. To ensure such complex functionalities, numerous protein channels are regulated
by physical and chemical stimuli that modulate their transport properties. Typical
examples are ion channels, which are necessary for the correct functionality of all cells.
Ion channels are passive and selective transporters controlled by external stimuli that act
upon them and modulate the electrical conductance and transport capabilities [7-9]. A
special class of transmembrane transporters consists of pore-forming toxins (PFTs),
which are among the most studied and well-understood class of membrane–binding
proteins [10-14]. Mostly of bacterial origin, PFTs significantly contribute to bacterial
virulence by targeting and inserting into host cell membranes. Consequently, PFTs
comprise about 25% of all known protein toxins of bacterial origin [11]. However, they
may be secreted by multiple organisms such as amoeba [12], cnidarian [13], earthworm
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[14], sea anemones [15], plants [16, 17] and even humans [18]. A salient feature of all
PFTs is that their interaction with components in lipid membranes leads to damage
manifested as an increase in permeability. The mechanism by which the membrane
barrier function is affected relies on their reconstitution into nano-sized transmembrane
pathways, or nanopores, which endow the target membrane with novel permeation
pathways and establish electrical connections. This feature has not escaped the attention
of scientists, who have explored and developed nanopore-based technologies to vertically
advance science, technology and medicine. Nanopores provide novel approaches for
biosensing, single molecule detection and characterization, sequencing, diagnosis, drug
delivery, and controlling membrane permeability [19-27]. Although these advances rely
on the ability of PFTs to introduce transmembrane conducting pathways, the biological
materials and associated methodologies are specifically tailored to each application, as
outlined in the following subsections.
The resistive pulse technique at the nano-scale
Current nano-sensing approaches based on the resistive pulse technique rely on
the deceptively simple Coulter principle developed decades ago [28]. A small hole
perforated in an electrically insulating material which separates two electrolyte-filled
reservoirs constitute the only electrical pathway through which an ionic current may be
established under application of an external voltage. When a particle moves through the
conducting pathway, it temporarily reduces the ionic flow and increases the electrical
resistance (resistive pulse), which is translated into a measurable decrease in ionic current
for the duration of the passage. The magnitude of the change in conductance is equated to
the size of the passing particle, making particle counting and size distribution
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measurements achievable. While biomedical and industrial applications benefit from
practical implementations of the Coulter principle, scientists began to investigate its
potential extension at the molecular level. The success of such an approach was
dependent upon the establishment of conducting pathways sized similarly to the
molecules under investigation. Since synthetic nanopores were not available [29],
explorations focused on using biological nanopores inserted into artificial lipid
membranes. As depicted in Figure 1, a typical nano-sensing device includes single
channels inserted into a bilayer lipid membrane (BLM) created in a hole made in a
hydrophobic film separating two electrolyte-filled reservoirs. The BLM serves as both
support for the inserted channels and the insulating partition between the conducting
solutions bathing it, such that the inserted nanopores are the only conducting pathways
between the two sides. The electrical connections established with Ag/AgCl electrodes
embedded in each of the reservoirs are used to apply the external driving voltage and to
measure the ionic currents through the channels by using sensitive amplifiers.

4

Figure 1.
The planar bilayer membrane set up. A lipid bilayer is formed in a tiny
hole in a polytetrafluorethylene (PTFE) film that separates the two electrolyte
solutions. The electrical connection is achieved by Ag/AgCl electrodes. The insertion
of single channels into a lipid bilayer membrane establishes the electrical connection.
The analytes can be identified, detected, or characterized on the basis of current
blockade and duration under the external electric field.
The principle of measuring at the nano-scale utilizes the Coulter principle and is
based on the analysis of the transient changes in ionic currents produced by the partial
occlusion of the conducting pathway during the passage of molecules. The original
Coulter approach employs a method of pushing the particles through the orifice by
pumping, which is not a valid option for the fragile membrane created between the two
reservoirs. Although diffusion alone may force neutral molecules to thread the nanopore,
the large entropic penalty presented by the small channel opening may significantly
reduce the rate of molecules translocated between the two sides. Partial compensation by
increasing the analyte concentration is not always feasible owing to the limited
availability or potential undesired interactions with the lipid membrane. Nonetheless,
many biomolecules are electrically charged, which present the opportunity to
electrophoretically drive the molecules through the nanopore. This development allowed
Kasianowicz et al. to demonstrate, for the first time, the translocation of single-stranded
DNA (ssDNA) molecules through a single alpha-hemolysin nanopore (α-HL, a water
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soluble toxin from Staphylococcus aureus) and to propose the use of nanopore-based
sensing for next generation sequencing [30-38]. Since this revolutionary discovery,
several other biological nanopores have been proposed for derived applications, such as
macromolecule detection and characterization, interaction studies, identification of
pathogens, diagnosis, controlled drug delivery, and nucleic acids and protein sequencing
[22, 27, 39].
Translocation studies using biological nanopores
In 1996, the study of α-HL for the passage of single-stranded DNA (ssDNA) or
RNA by Kasianowicz et al., using the resistive pulse technique, led to a revolution in the
field of nanopore technology [30]. Since then, nanopores have been widely explored for
single molecule identification and characterization, sequencing, conformational analysis,
orientation determination, and to study the interactions of molecules. α-HL, the most
commonly used nanopore, is a mushroom-shaped, long, heptameric, β-barrel
transmembrane protein of 10 nm height and has a diameter in the range of 1.4–2.6 nm
(Figure 2) [40]. The α-HL nanopore is able to distinguish between purine and pyrimidine
homo-polymers based on their characteristic features that include dwell time and current
blockage, leading scientists to envision its use for sequencing purposes [31, 41]. The long
β-barrel, which can accommodate ~10-15 nucleotides, and the high speed of the analyte
through the pore during translocation preclude individual nucleotide recognition.
However, addition of chemical tags to specific nucleotides improves the spatial resolution
and enables base-specific identification [42].
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a.

b.

nm

10 nm

2.6

10 nm
Figure 2.
Structure of α-HL. a) α-HL is a mushroom shaped β-barrel protein of
height 10 nm. b) The top view of the structure indicates the seven subunits (shown in
different color) with the pore diameter of ~ 2.6 nm. The protein is also characterized
by the presence of a vestibule and the narrow constriction of size ~ 1.5 nm (which is
not shown in the figure). Adapted from Song et al. (1996), PDB 3ANZ [40])
An improvement in the ability to identify the four DNA nucleotides is achieved
by using biotinylated ssDNA conjugated with streptavidin and nucleotide recognition
sites present in the lumen of the α-HL nanopore [43]. However, this approach precluded
full translocation of the conjugated DNA molecule, which was immobilized by α-HL
nanopores. The magnitude of the residual currents achieved after immobilization is
sequence-dependent [43]. Further improvements of this approach aimed at enhancing the
energy barrier for ion movement and demonstrated an improved ability for base
discrimination [44]. Another approach utilizes the synthesis method where a DNApolymerase complex is attached to the nanopore and, during DNA synthesis, the distinct
tags from the complementary-nucleotide enter the pore and provides unique electronic
signatures for accurate base discrimination [45, 46]. A different strategy employs
conjugating an E.coli exonuclease to a nanopore [47]. The nuclease cleaves the
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nucleotides, which are further detected during translocation through the nanopore,
narrowed by introducing an amino-β-cyclodextrin ring as a molecular adapter. All these
advancements led to the launching of a first device intended for nanopore sequencing
(MinIon) by Oxford Nanopore Technologies in 2014 [19, 48].
Although α-HL has received the most attention in the field of nanotechnology for
sequencing purposes, other nanopores have emerged as promising tools for nanopore
based sequencing. For example, Mycobacterium smegmatis porin A (MspA) is an
octameric bacterial porin that has a constriction of 1.2 nm and a length of 9.6 nm (Figure
3) [49]. The presence of the narrow constriction equipped MspA with improved spatial
resolution compared to α-HL. An engineered MspA was first demonstrated in 2008 for
the detection of ssDNA molecules [50]. The immobilization of ssDNA inside the MspA
nanopore, either by using complementary strands or biotin-neutravidin complex, allows
discrimination between the four nucleotides [51, 52]. Similar to the study using α-HL, the
combination of engineered MspA with phi29 DNA polymerase provided the
discrimination of nucleotides with a good correlation between the current pattern and
known DNA sequence and implicated MspA as one of the strong aspirants in the race of
nanopore-based sequencing [53].
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a.

9.6 nm

b.

1.6 nm

Constriction
8.8 nm
4.9 nm
Figure 3.
Structure of the MspA pore. a) MspA is an octameric β-barrel of height
~9.6 nm and characterized by the presence of a small constriction. b) The top view
shows the eight subunits and constriction of diameter ~1.6 nm. (Adapted from Faller
et al. (2004), PDB 1UUN [49])
Even though nanopores have been mostly exploited for the development of rapid,
accurate, and inexpensive sequencing tools, scientists have also found applications for
other purposes. The α-HL nanopore can be used for the characterization of neutral
molecules such as poly-ethylene glycol (PEG) [54]. The translocation of PEG of different
molecular masses produces distinct current drops and residence times. Further analysis
suggests that the characteristic features generated from the passage of different PEG sizes
depend on the mobile cation concentration inside the pore and the attractive interaction
between the pore and polymer [55]. In addition, both α-HL and MspA have demonstrated
the potential to identify epigenetic markers including 5-methylcytosine and 5hydroxymethylcytosine in DNA strands [26, 56]. α-HL has also been investigated for the
identification and detection of chemically-modified nucleotides, mismatches, base pairing
of oxidized bases in duplex DNA, or to characterize the inter-strand cross-link in duplex
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DNA [57-60]. Besides polynucleotides, protein nanopores were also explored for the
translocation and characterization of peptides and proteins, which may provide novel
tools for peptide sequencing and structure determination [61-63]. The rate constant
obtained from the transport of cationic peptides through α-HL depends on the applied
transmembrane voltage and peptide length, thereby adding other parameters for the
characterization of polypeptides using nanopores [61]. Also, the charges inside of the
pore can significantly affect the association and dissociation constant during the
translocation of cationic polypeptides by altering the energy barrier [64]. Translocation of
partially folded and unfolded maltose-binding proteins through α-HL in the presence of
denaturing agents suggested that completely unfolded proteins produce short blockades
while partially folded proteins give rise to long blockades [65]. Folded and unfolded
peptides with β-hairpins demonstrated similar effects supporting the use of α-HL for
studying the structure of proteins [66]. Proteins were also translocated via α-HL
facilitated by an unfoldase enzyme, where the enzyme unfolds and translocate the protein
in an ATP-dependent manner [67].
Aerolysin, a pore-forming toxin secreted by Aeromonas hydrophila, was
employed for the characterization of polymers including polynucleotides and
polypeptides. It forms a vestibule-less mushroom-shaped heptameric β-barrel pore of a
diameter approximately 1.0 – 1.7 nm (Figure 4) [68-70]. Aerolysin was first employed in
2006 as an analysis tool for translocation of α-helical peptides [62]. Since this time,
aerolysin has found applications in the study and characterization of
oligo/polynucleotides [71, 72], chimera proteins [73], proteins [74-76], and
oligosaccharides [77, 78].
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Figure 4.
Structure of aerolysin derived from the quasipore map. Aerolysin is a
mushroom-shaped β-barrel structure of length ~8.9 nm and has a dimeter of 1 - 1.7
nm. [70]
Biosensing with pore-forming poteins
The stochastic sensing of analytes using nanopores offers great advantages
through their versatility and sensitivity. It allows the sensing of molecules like
therapeutic agents, toxins, biological weapons and other pollutants [79-81]. Various
metal ions such as copper ions, lead, barium, and zinc were detected using an engineered
α-HL protein nanopore [20, 81, 82]. The substitution of seven amino acids to create a
ring of aromatic amino acids within the lumen of α-HL distinguished 2,4,6-trinitrotoluene
from other nitro-aromatics [83], and an engineered α-HL was also shown to detect
biologically significant phosphate anions [84]. The incorporation of an adapter like
cyclodextrin within the lumen of α-HL enabled the nanopore to sense various organic
analytes including antidepressant and antihistaminic drugs [85]. In addition to
cyclodextrin, cyclic peptides used as molecular adapters in the β-barrel of α-HL allow it
to function as an exquisite sensor for the detection of small polyanions [86]. The
attachment of biorecognition elements in the protein nanopore provides another platform
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for the use of protein nanopores as biosensors. The attachment of biotin-PEG to the α-HL
lumen enabled the detection of streptavidin molecules [87]. Similarly, coupling
disaccharide molecules to α-HL allowed for studying the binding kinetics with a ligand
lectin, a carbohydrate binding protein from Bauhinia purpurea [88]. In line with their
outstanding sensing capabilities, nanopores are exploited for early diagnosis and disease
management [89]. Biomarkers for lung cancer and human epithelial carcinoma were
successfully detected with nanopores at very low concentrations, indicating a tremendous
potential for biomedical uses [24, 90].
Biological nanopores as nano-switches for controlled transport
The ability to introduce molecules such as antibodies, drugs, dyes, or therapeutic agents
into cells in a non-destructive way is essential for qualitative and quantitative descriptions
of fundamental cellular processes and for modulation of crucial functionalities. The
loading of bioactive molecules into living cells is challenging due to the selective nature
of the plasma-membrane. To overcome the membrane barrier, protein channels are
excellent tools with the ability to permeabilize the membrane without destroying the cell.
The widely used nanopore α-HL was developed into a metal-actuated nano-switch for
controlling the permeabilization of cell membranes [91]. The replacement of five aminoacids with histidines provided α-HL with the additional feature of turning the membrane
permeability on/off simply by adding or removing Zn2+. The cholesterol dependent
cytolysin streptolysin O, a toxin from streptococci, produces a large pore and is able to
deliver cell-impermeant molecules up to 100 kDa in adherent and non-adherent cell lines
[92-94]. Listeriolysin-O, a toxin from Listeria monocytogenes, is able to efficiently
deliver a viral nucleoprotein and a macromolecule antigen to cytotoxic T-lymphocytes
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[95-97]. In these studies, listeriolysin O was encapsulated inside liposomes for the
efficient cytosolic delivery of molecules. The bacterial mechanosensitive channel MscL
from E. coli may provide nanoscale pathways for delivering cell-impermeable cargoes
into the cytosol without killing the host cells [98]. Moreover, engineered MscL was
proposed to be used in artificial membrane systems for drug delivery from pressurized
liposomes [99].
Limitations of existing natural nanopores
In spite of their tremendous potential as scientific and engineering tools,
nanopores have intrinsic limitations. The small opening of the conducting pathway
constitutes a major barrier for larger analytes. The vestibular structures often present in
their structure complicate the interaction kinetics and interpretation of experimental data.
Not all biological nanopores used for sensing and permeabilization are commercially
available, thus on site production and purification may be needed. Insufficient
characterization, difficult reconstitution, or poor stability in artificial and natural lipid
membranes may significantly restrict their applicability. Also, the lack of intrinsic
regulatory mechanisms often hinders their use for controlled transport, and the
endowment with such features is not always straightforward. Ideally, a versatile nanopore
should be useful for both sensing and controlled transport purposes. To meet this
stringent need, we propose using lysenin.
Lysenin as a prototype channel for sensing and controlled permeability
The limitations presented by the biological nanopores used for sensing and
permeabilization raises the question about whether a particular wild type protein may
constitute a better alternative for the development of nano-tools with a greater
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applicability. Along this line, our work focused on investigating lysenin as a
transmembrane transporter capable of both stochastic sensing and achievement of
controlled membrane permeability. Lysenin is a 297 amino acid protein found in the
coelomic fluid of the earthworm E. fetida [100-102]. Early studies identified significant
cytolytic and hemolytic activities [102-104], as well as a strong ability to disturb smooth
muscle contraction [102, 105]. It’s lytic activity is selectively restricted to membranes
rich in sphingomyelin [100, 101, 104, 106, 107], which is a major component of animal
cell plasma lipid membranes. Transmission electron microscopy (TEM) imaging and
electrophysiology studies confirmed a lytic mechanism, which relies on lysenin
oligomerization into large transmembrane pores inserted into host artificial and natural
membranes [14, 108-110]. The complete mechanism of channel formation is yet
unknown and currently there is no agreement on the number of monomers required to
assemble a functional pore. TEM imaging suggested a hexamer [14] and electron density
map a trimer [111], while the most recent structural data points to a nonamer [109]. In
spite of such discrepancies, all investigations indicate a large, central large pore of up to
~3 nm in diameter in the center of the oligomerized structure [103, 104, 106, 108].
The recently deciphered lysenin structure (Figure 5) shows a long β-barrel
channel of ~11 nm in length and indicates the absence of a vestibule [109, 112].
Lysenin’s ability to self-insert large and stable nanopores in artificial membrane systems
creates the opportunity to use it as a single molecule sensor in a Coulter setup employing
stochastic sensing similar to other biological nanopores. The first attempt to translocate
DNA molecules through a single wild-type lysenin channel failed, which was explained
by strong electrostatic repulsion between the highly-charged channel domains and the
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DNA molecules [109]. The replacement of some negatively-charged amino acids with a
combination of neutral and positively charged amino-acids yielded transient changes of
the ionic current through single lysenin channels, resembling translocation events [109].
However, no further proof of the translocation of DNA molecules through the
recombinant channel was provided.

11 nm

a.

b.

1.6-2.5 nm

12.3 nm
Figure 5.
The structure of the lysenin pore. a) Lysenin is a nonameric mushroom
shaped β-barrel protein with a length of ~11 nm. b) The top view indicates the nine
subunits and a pore size of ~1.6-2.5 nm in diameter. (Adapted from Podobnik et al.
(2016), PDB 5EC5 [109])
To demonstrate that wild-type lysenin channels may be used as stochastic sensors,
we employed angiotensin II (Ang II) as analyte, which is an octapeptide hormone (AspArg-Val-Tyr-Ile-His-Pro-Phe) that plays a central role in cardiovascular homeostasis
[113, 114]. This choice was also motivated by the fact that Ang II bears a fractional
positive charge at neutral pH, which may prevent undesired electrostatic repulsions
between the cationic peptide and anionic domains present within the channel structure of
lysenin [109].
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In addition to investigating lysenin channels as single molecule sensors, our
efforts expanded into the use of lysenin channels for controlling the permeability of
artificial and natural membranes. This component makes exclusive use of lysenin’s
unique features regarding its transport capabilities. The large conducting pathway ensures
a high transport rate, which is common to many PFPs and ion channels. However, unlike
many other PFTs, lysenin channels are highly regulated by a multitude of physical and
chemical stimuli [115-120], enabling multiple opportunities to achieve controlled
transport. The non-symmetrical voltage-induced gating presented by lysenin is not
common among PFTs [110, 118, 119]. Many PFTs do present conductance modulation
by voltage, however it is symmetric and occurs at unusually large magnitudes of the
transmembrane voltage [10]. Lysenin reconstitution into artificial membrane systems at
single and multiple channel levels shows a sudden change from a highly-conducting state
to a non-conducting state at transmembrane voltages greater than ~15 mV [110, 118].
The open-close transition is presumed to originate in fast conformational changes
induced by interactions between the external electric field and a voltage-domain sensor
present in the channel’s structure [110, 118]. The changes in the conducting state are
reversible and the channels re-open after the elimination of the external electric field or
through the application of negative bias voltages [110, 118]. Controlled permeabilization
via transmembrane voltage manipulation is not so straightforward for live cells, since
they present a resting transmembrane potential. Nonetheless, even in living cells,
transmembrane potentials may be adjusted by either creating diffusion potentials or by
exposing the cells to strong electric fields [121]. Such investigations would benefit
significantly if lysenin channels were inserted in and inside-out configuration (i.e., by
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microinjection), which would force the lysenin channels into the closed state at
physiological transmembrane potentials. Further voltage manipulation may be achieved
through membrane polarization under the influence of strong electric fields [121].
Consequently, such manipulations are absolutely feasible in artificial membrane systems
for which the transmembrane potential may be varied without affecting the integrity of
the system under investigation.
Another feature of lysenin channels, crucial for permeability studies, is their
unique regulation by multivalent ions [115-117]. Early studies conducted by our group
identified several distinct mechanisms of interaction between lysenin channels and
multivalent cations [116, 117]. The exposure of lysenin to sub-mM concentrations of
trivalent metal cations such as lanthanides or Al3+, elicited a rapid decrease in the
macroscopic conductance, as inferred from the sustained decrease of the ionic current
through multiple lysenin channels inserted into planar membranes [116, 117]. Singlechannel experiments demonstrate a fast transition between conducting and nonconducting states elicited in the presence of such multivalent metal cations, suggesting a
ligand-induced gating mechanism [116, 117]. This essential feature may prove fruitful for
exclusive control over membrane permeability by using multivalent cations. In addition,
the ligand-induced gating is reversible; the removal of the conductance-inhibiting ions by
chelation or precipitation yielded 100% recovery of the membrane conductance,
explained by the re-opening observed at single-channel levels [116, 117]. Another
important feature of ligand-induced gating is the partial channel closure, manifested in
the presence of divalent metal cations or more voluminous, yet multivalent, organic ions
[116, 117]. While the resulting sub-conducting states do not completely annihilate the
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macroscopic conductance and lysenin-induced permeability, the smaller opening of the
conducting pathway may be used for size-selective transport of various molecules across
membranes. Also, our recent explorations present reversible channel conductance
modulation induced by purines [115], which is detailed in this dissertation.
Permeability control by multivalent ions may constitute an excellent option for
artificial membrane systems, which are capable of sustaining the addition of metal ions,
chelators, or precipitating agents. However, many of those may prove toxic for living
cells, thus restricting their applicability [11]. To avoid such limitations, we used another
unique and remarkable feature of lysenin channels, namely irreversible blockage by
chitosan [120]. Chitosan is a highly charged linear polysaccharide consisting of N-acetylglucosamine and glucosamine with β-1, 4-linkages. It is a product obtained from
crustacean shells, and it is considered bio-inert and non-toxic to animals and humans
[122, 123]. These life-compatible features support the use of chitosan as an optimal
choice for controlling the permeability of live cell membranes in conjunction with
lysenin. The two-step process comprising cell permeabilization with lysenin channels
followed by chitosan-induced blockage would provide a two-way control over the
membrane barrier while preserving cell viability.
Objectives
The major goal of our research was to investigate lysenin channels as both nanosensors for stochastic sensing and as nano-switches for controlled permeabilization of
artificial and natural lipid membranes. To achieve the proposed goal, my work focused
on two distinct objectives:
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Objective 1: Investigate the translocation of angiotensin II through single lysenin
channels inserted into artificial planar lipid membranes
Ang II translocation through single channels inserted into planar lipid membranes
was explored through the resistive pulse technique. The transient changes in the ionic
current upon peptide-channel interactions were analyzed with specialized software to
determine amplitude and dwell time. The influence of applied voltage on the electronic
signature, in conjunction with previous interpretations on macromolecule-channel
interactions, enabled discrimination between putative translocations and channel-peptide
collisions. The density plot of recorded events identified an excellent
translocation/collision separation, which is unmatched in translocation experiments
employing other channels and short peptides. Separate experiments that employed large
populations of lysenin channels and extended time allowed mass spectrometry and liquid
chromatography identification of electrophoretically-driven peptide translocation only
through un-blocked lysenin channels.
Objective 2. Exploit lysenin regulatory properties for controlling the permeability of
artificial and natural membrane systems
The ability to control the membrane permeability was tested in artificial
membrane systems (bilayer membranes and liposomes) and in the plasma membrane of
live cells (Jurkat and ATDC5). Our explorations indicated that ATP may be used to
reversibly modulate the macroscopic ionic conductance of lysenin channels in single and
multiple channel experiments. Next, assessments enabled the analysis of diffusive
transport of membrane impermeable calcein dye into lysenin-permeabilized liposome
membranes. The addition of multivalent Al3+ cations induced simultaneous channel
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blockage and quenching of non-entrapped calcein, which facilitated microscopy imaging.
In addition, multivalent metal cation removal by precipitation reverted the membrane to a
highly permeable state and initiated calcein leakage into the bulk solution. Further
experiments on lysenin-induced live cell permeabilization employed non-permeant dyes,
dead/live dye indicators, and lysenin channels blockage by chitosan. Separate
electrophysiology investigations were aimed at deciphering lysenin’s potential
interactions with dyes in order to eliminate any undesired interference with the biological
system under consideration. Permeability and viability estimations were employed using
confocal microscopy and fluorescence spectroscopy as major techniques for qualitative
and quantitative assessments.
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CHAPTER TWO: TRANSLOCATION OF ANGIOTENSIN II THROUGH LYSENIN
CHANNELS
Abstract
Here we show that single wild-type lysenin channels inserted into artificial lipid
membranes may function as stochastic sensors for peptide molecules by using the
resistive-pulse technique. The interactions between angiotensin II and single lysenin
channels inserted into planar bilayer lipid membranes yielded transient changes in the
ionic open current established through the channel’s conducting pathway. Further
analysis of the recorded transient events, in terms of current blockage and dwell time
allowed us to identify two distinct classes of events. These events were classified either
as putative translocations or collisions. To aid data interpretation, we analyzed the
influence of applied voltage on both current blockage and dwell time distribution
characteristic to each event class. To irrefutably demonstrate that angiotensin II
molecules cross the membrane through open lysenin nanopores, we performed extended
experiments comprising thousands of inserted channels together with qualitative and
quantitative analysis by employing liquid chromatography – mass spectroscopy. The
translocated molecules were detected only when the membrane contained lysenin
channels in the open state and the electric field had such an orientation to
electrophoretically drive the peptides towards the membrane. Taken together, our studies
demonstrate that un-modified lysenin channels may be used for stochastic sensing of
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macromolecules, which may open novel avenues for single molecule detection and
characterization, biosensing, early diagnosis, and sequencing.
Introduction
The ultra-small ionic currents established through a biological or synthetic
channel embedded into an otherwise insulating membrane may suffer minuscule yet
measurable changes upon interactions between the nanopore and molecules in solution
[1-4]. This broad measuring principle emerged into numerous nanopore-based
technologies intended to revolutionize science, technology and medicine by utilizing the
ultimate sensitivity at the molecular or sub-molecular scale. More than two decades ago,
Kasianowicz et al. demonstrated that polynucleotides may translocate through alphahemolysin (α-HL) nanopores reconstituted into artificial bilayer lipid membranes (BLMs)
[1]. This early work employed the resistive pulse technique in which a voltage-clamp
setup is used to measure changes in ionic currents when molecules are passing through
single channels [1]. At this early inception, the ambitious idea of using nanopores for
fast, cheap and reliable DNA sequencing emerged, which started a scientific and
technological race around the world. DNA sequencing, the big prize of the race, received
the most attention from scientists who engaged in numerous experimental and theoretical
explorations on nanopore sequencing. Novel synthetic and biological nanopores have
been exploited as candidates for sequencing, and multiple measuring principles have been
proposed [4-11]. As a result of the rapid advancement in this field, Oxford Nanopore
Technology, in 2014, launched the MinION Access Program, providing early access to
the first portable nanopore-based sequencer, and several studies reported accurate
readings of increased DNA length [12-18].
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However, in depth explorations of nanopore-based technologies are more and
more focused on detection, identification, and characterization of proteins and their
interaction [7, 19-23]. Peptides and proteins hold a significant importance in living
organisms as they play critical roles in the onset of cancer, neurodegenerative disorders,
and infections [24-26], and often their expression levels correlate with disease [27-29].
Several studies have explored natural nanopores for peptide and protein sensing including
α-HL, aerolysin, phi29 connector channel, and ClyA [9, 19, 30-34]. However, α-HL and
aerolysin, both have a narrow size constriction of ~1.4 nm which limits their applicability
for structural analysis of peptides. The viral phi29 DNA packaging system has a wider
diameter of 3.6 - 6 nm, which is able to translocate double-stranded DNA, but needs to be
first reconstituted into liposomes and then incorporated into the lipid planar bilayer
membrane, making the process tedious [8]. The larger protein channel, ClyA is able to
translocate and detect folded proteins, but this nanopore exists in different oligomeric
states and requires further purification before use [32, 33]. Synthetic nanopores are
scalable, chemically and mechanically robust, but their production may not ensure a high
geometric repeatability [35-37]. Biological nanopores offer unsurpassed structural and
dimensional repeatability, and often their sensing capabilities may be tailored by
chemical modifications or bio-engineering [9, 38-40]. In the pursuit of finding novel,
efficient and better nanopores, we propose lysenin as a new sensing tool for nanoporebased technologies.
Lysenin is a nonameric pore-forming toxin extracted from the coelomic fluid of
the earthworm E. foetida which self-inserts into the BLMs containing sphingomyelin [41,
42, 43]. Recent studies show that the lysenin channel is a long β-barrel of ~9 -11 nm with
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a large pore diameter (~2.5 nm) [41, 42]. In contrast to other pore-forming toxins, lysenin
is regulated by voltage, ligands, and polymeric cations [44-49]. Owing to its large
conductance and outstanding stability when reconstituted into artificial lipid membranes,
we hypothesized that lysenin is an exceptional candidate for analysis and
characterizations of single macromolecule by using the resistive pulse technique. In the
present study, we employed electrophysiology techniques to investigate the interactions
between angiotensin II, an important cardiovascular peptide and single lysenin channels
inserted into planar membranes. The translocation of peptides was confirmed by liquid
chromatography-mass spectroscopy (LC-MS) analysis of the analyte electrophoretically
driven through large populations of lysenin channels.
Materials and Methods
Preparation of bilayer lipid membrane and single channel insertion
A classic BLM setup was used for membrane preparation, channels insertion, and
peptide translocation experiments [49-51]. The bilayer chamber (Figure 1) consisted of
two ~1 ml reservoirs made out of polytetrafluoroethylene (PTFE) and separated by a thin
PTFE film (120 μm thickness). The film was pierced by a high-voltage electric spark and
the resulting hole (~60 µm diameter) was painted with less than 1 μl lipid mixture
containing diphytanoyl phosphatidylcholine (Avanti Polar Lipids), sphingomyelin
(Avanti Polar Lipids), and cholesterol (Sigma-Aldrich), weight ratio 4:2:2, and dissolved
in n-decane. The use of neutral lipids was justified by the need to maximize suppression
of the voltage induced gating that manifests at positive potentials for lysenin channels
inserted into charged membranes [46, 49]. The two reservoirs were filled with 1M KCl
buffered with 10 mM Tris and 1 mM EDTA (pH 6.9). Two Ag/AgCl electrodes
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immersed into the electrolyte solutions on each side of the membrane were used for
electrical connections to the Axopatch 200B amplifier (Molecular Devices) set in the
voltage-clamp mode. The analog signal from the amplifier was fed into the Digidata
1440A Digitizer (Molecular Devices) for online visualization and digital recording with
the Clampex 10.5.2.6 software package (Molecular Devices). The lipid membrane
formation was monitored by capacitance measurement, and the bilayer integrity was
checked by measuring the seal resistance at 100 mV bias potential. For a 60 µm hole in
the PTFE film, a good bilayer was confirmed by measuring a capacitance larger than 65
pF and a seal resistance greater than 500 GΩ.
After the bilayer membrane formation, single channel experiments comprised of
channel self-insertion by the addition of 1 μl of 100 nM lysenin solution (Sigma-Aldrich)
to the cis (ground) reservoir. Continuous mixing of the electrolyte solution during
insertion at -60 mV bias potential was performed with a low noise Bilayer Magnetic
Stirrer (Warner Instruments). To prevent further insertions, after reconstitution of one or
few lysenin channels in the membrane, the reservoir was flushed with 30 ml of lyseninfree buffered electrolyte solution.
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Figure 1.
The experimental setup for Ang II translocation employs single lysenin
channels inserted into planar bilayer lipid membranes.
Translocation of angiotensin II through single lysenin channels inserted into lipid
membranes
Ang II was added at a final concentration of 1 μg mL-1 into the appropriate reservoir and
the solutions stirred for ~ 10 seconds at maximum speed to ensure uniform mixing. Data
recording was performed in dual-channel mode by using the variable-length protocol at a
sampling rate of 250 ksample/s, 10 kHz hardware filter, and 1ms post- and pre-trigger
length. Digital data saved in the abf format have been further analyzed with Clampfit
10.2 (Molecular Devices), Transalyzer [52], Matlab (Mathworks), and Origin 8.5
(OriginLab Corporation) software packages. The Transalyzer package was set to
calculate the dwell time as the Full Width Half Maximum for each individual event. The
average level between the first and the last local minima of each event selected for
analysis was used to compute the current blockage [52].
Insertion of large populations of lysenin channels into membranes
An experimental protocol similar to that for single channels was employed for
insertion of multiple channels into the bilayer membrane. To accommodate a larger
number of channels, the diameter of the hole in the PTFE film was increased to ~180 µm
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by applying multiple electric sparks to a film pre-drilled with a thin needle. The volume
of the electrolyte reservoir was lowered to 100 μl and a higher amount of lysenin was
added to the cis reservoir for insertion. The number of channels residing in the membrane
was estimated from the slope of the I-V curve recorded for a narrow voltage range
(Figure 2) and by accounting for the individual channel conductance (which is ~ 2.03 nS
in otherwise identical experimental conditions). Multiple channel experiments comprised
~ 22,700 channels; when required, the number of the inserted channels was up-adjusted
by successive addition of lysenin to the electrolyte solutions.
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Figure 2.
The I-V plot obtained after the insertion of large populations of lysenin
channels into BLM. The slope of the curve was calculated to determine the
macroscopic conductance and hence the number of channels inserted to the
membrane. (Adapted from Shrestha et al. (2017) [53])
Ang II translocation through large populations of lysenin channels comprised
addition of 10 µg peptide to the cis reservoir while biasing the membrane by -100 mV for
~36 hours. To avoid evaporation, both reservoirs were covered with small pieces of
parafilm or silicone films. Each bilayer was checked for integrity at the end of
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experiments and the failed ones discarded from analysis. One control experiment
employed membranes biased by opposite voltages (+100 mV, to electrophoretically drive
the peptide away from the membrane). The second control comprised irreversible
blockage of lysenin channels by cis addition of 5 µL of 0.1% (m/v) chitosan solubilized
in 0.1M acetic acid. The addition of this strong inhibitor of lysenin’s conductance [54]
yielded a rapid decrease of the ionic current (Figure 3), hence indicating channel
blockage. Next, Ang II was added to the ground reservoir, both reservoirs were covered
to prevent evaporation, and the membranes biased by -100 mV for 36 hours.
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Figure 3.
Chitosan addition induced a sustained and irreversible decrease of the
macroscopic conductance, indicative of channel blockage. (Adapted from Shrestha et
al. (2017) [53])
Liquid chromatography-mass spectroscopy analysis of angiotensin II translocated
through large populations of lysenin channels
Translocated samples from the trans reservoir were carefully collected after
running the experiment for extensive time without disturbing the lipid membrane. The
samples were analyzed using Bruker maXis quadrupole-time-of-flight (Q-TOF) mass
spectrometer with an electrospray ionization (ESI) Source (Bruker Daltonics). A Dionex

38
Ultimate 3000 LC system (Dionex) was attached with ESI-Q-TOF. Samples placed in an
autosampler at 4°C were injected into C18 column (150 x 2.1 mm, 4 µm, Phenomenex)
and the temperature was maintained at 40 °C for chromatographic separation. The elution
mobile phases for LC comprised of 5% acetonitrile with 0.1% formic acid (solvent A)
and pure acetonitrile with 0.1% formic acid (solvent B). The LC flow rate was kept at
200 µl/min and the elution began with 0% B for 9 mins, 25% B for over 10 mins, 60% B
for over 11 mins, and held at this percentage for additional 21 mins. Mass spectrometry
was achieved in positive ion mode with a spray voltage of 3000 V with an endplate offset
at -500 V, dry gas flow rate at 8.0 L/min, nebulizer gas pressure at 1.5 bar, and dry gas
temperature at 200 °C.
Results and Discussion
Electrical detection of interactions between angiotensin II and lysenin channels
Before lysenin addition, the absence of any conducting pathway was indicated by
the absence of ionic currents through the planar BLM, which is an insulator. The step
wise variation of the ionic current after lysenin addition at -60 mV bias potential was
indicative of channel insertion (Figure 4a). The ratio I/V directly provided the individual
conductance of a channel (~ 2 nS), which is larger than what was previously estimated
from measurements performed in low ionic strength conditions. However, there is no
inconsistency with our measurements owing to the large ionic conductivity presented by
the 1 M KCl support electrolyte solution. The same individual channel conductance was
estimated after insertion of two lysenin channels into the membrane biased by -80 mV
(Figure 4), indicative of channel uniformity.
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A steady and quiet baseline of the ionic current through two lysenin channels was
observed at -80 mV and high temporal resolution before adding the analyte to be studied,
indicate the absence of gating. The remarkable low noise of the trace (< 2.6 pA RMS at
10 kHz bandwidth) suggests an excellent suitability of lysenin channels for
discriminating very small changes of the ionic currents, hence indicating an improved
sensitivity. Addition of 1 μg ml-1 Ang II into the trans (headstage) reservoir at -80 mV
bias potential elicited no changes of the ionic currents recorded in otherwise similar
conditions (Figure 4c). This is a clear indication of the absence of interactions between
channels and analyte molecules. However, analyte addition to the cis (ground) reservoir
at the same concentration elicited numerous transient changes of the ionic current,
suggesting strong interactions between the peptides and inserted channels [7, 21-23, 5559]. These first observations point out that channel-analyte interactions are promoted
only for particular orientation of the external electric field. Ang II bears a small positive
charge near neutral pH and it is expected to interact with electric fields. The electric field
inside the bulk electrolyte solution is very low owing to the high conductance but it is not
negligible. Apparently, the peptides added to the trans reservoir are electrophoretically
driven away from the membrane. The random thermal motion may bring the peptides
close to the channels but the increasing fringe electric field may drive them away. The
electric field increases considerably as the peptides move closer to the pore opening and
the resulting electric force will drive the analytes away therefore preventing penetration
into the channel. By switching the direction of the electric field, the peptides are
electrophoretically driven towards the nanopore, captured by the fringe electric field, and
forced to translocate through the channel by the large transmembrane electric field. A
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closer inspection of the transient electronic signature (inset Figure 4d) shows transient
changes in the ionic currents typical to molecule translocation through nanopores.
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Figure 4.
Interactions of Ang II with single lysenin channels produce transient
changes in ionic currents. a) Insertion of a single channel into the lipid membranes
containing the electrolyte solution (1 M KCl with 10 mM Tris and 1 mM EDTA, pH
6.9) results in an increase magnitude of current at -60 mV transmembrane potential
(sampling time 1 s, 1 kHz low pass hardware filter, and 10 Hz low pass software filter).
b-c) Absence of transient changes in the ionic current via single lysenin channels at 80 mV when Ang II b) was not added to the reservoirs and c) added only to the trans
side. d) Addition of the peptide to the cis reservoir at -80 mV produced temporary
blockages in the ionic current, indicating the interaction between the single lysenin
channels and Ang II. (Adapted from Shrestha et al. (2017) [53])
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Event analysis, classification, and interpretation
The transient changes in the ionic currents elicited by interactions between
lysenin channels and Ang II clearly resemble electronic signatures observed in prior
experiments comprising biological nanopores and peptides [7, 19, 23, 56-59]. To provide
an in-depth analysis of the recorded events, we further analyzed transients by estimating
the average current change during the transient blockage, <IB>, and the dwell time, tD,
with the Transalyzer software package, specifically developed for analysis of
translocation data [52]. The events recorded at -80 mV were analysed with Transalyzer
software and the density map was plotted with Origin software (Figure 5a). We
immediately observed that the events are clustered into two distinct classes, which we
named E1 and E2. Such clustering is typical for macromolecule translocation through
either synthetic or natural nanopores [7, 19, 56, 60], and may originate in unsuccessful
translocation attempts when the molecules only collide with the channel opening [7, 56],
different orientation of molecules entering the nanopore [4], folding, oligomerization
[19], or analyte binding to the pore lumen [59].
What is obvious is that the two classes of events are quite distinct, which is not
common for translocation experiments employing peptides as analytes. Given the large
separation of the two classes, we succeeded to perform individual analyses on each class,
which allowed a better interpretation of the origin of clustering. The <IB> distributions
were narrow and symmetric (Figure 5b), with peaks centered at ~26 pA (E1 events) and
~10 pA (E2 events).
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Figure 5.
Analysis of transient blockages of the ionic current after addition of
Ang II to the cis reservoir at -80 mV produces two types of events. a) The density plot
indicates two clearly distinguishable events type E1 and E2. b) Distribution of <IB>
histograms (bin width 3 pA) gives peak currents of E1 events at ~26 pA and E2 events
at ~10 pA, respectively. c) Distribution of tD histograms (bin width 0.02 ms) presents
peak of E1 events at ~70 µs and E2 events at ~120 µs, respectively. In order to clearly
distinguish the overlapped distribution, a gap between the bins for the E2 events was
included. (Adapted from Shrestha et al. (2017) [53])
Both values of the average current blockage are very small relative to the open
current (less than ~25%), while other translocation experiments employing peptides or
short polynucleotides interacting with synthetic or biological nanopores report larger
ratios [6, 7, 11, 23, 56]. To explain this particular observation, we inspected the physical
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properties of the channel and peptide. The lysenin channel is uniform and has a length of
~ 10 nm, which is comparable to the aerolysin channel and longer than α-HL. Structural
data and electrical measurements indicate that the lysenin channel diameter is larger than
either aerolysin or α-HL, thus suggesting larger inner volume of the conducting pathway.
The analyte Ang II is a short peptide consisting of only eight amino acids. The contour
length of the peptide is not known but we may assume it is shorter than the peptides
containing more amino acids and tested for translocation in experiments comprising αHL or aerolysin [7, 56]. The small contour length and hydrodynamic diameter of the
peptide compared to the nanopore suggest that analyte passage may elicit relatively small
changes in the ionic currents by displacing only a fraction of the total volume; such a
feature has been previously reported for translocation of short peptides through the large
channel of hetero-oligomeric channel from Nocardia farcinica [59].
Further analysis of the events recorded at -80 mV in terms of dwell time
distribution (Figure 5c) showed skewed, non-symmetrical and overlapped histograms for
the two event types. In addition, the E2 distribution spanned a broad range of dwell time
values, while the E1 distribution was narrower, and such features were also observed in
the density plot presented in Figure 5a. The major peaks at ~70 µs (E1 events) and ~120
µs (E2 events) were still well separated but the skewness clearly produce large
discrepancies between peak and average values. In spite of such shortcomings, the time
distributions are different than what is customarily presented for translocation of peptides
and short polynucleotides through biological channels, i.e. exponential decays described
by characteristic relaxation times as a measure of mean tD [7, 11, 19, 21, 23, 56, 59]. In
addition, these previous analyses “force” an exponential distribution of the dwell time,
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which presents several notable drawbacks. An exponential distribution tacitly assumes
that the maximum value is obtained for a dwell time close to zero. However, irrespective
of the recording device, shorter events are always filtered and their shape significantly
altered. Also, to eliminate the high frequency noise, a low-pass filter is always employed
for data recording, which may critically affect short events by changing their shape and
shift the time distribution. Nonetheless, our results cannot be accurately described as a
combination of exponential decays. Given the electrical quietness of the lysenin channels,
we successfully triggered the event recording such that the electrical noise was eliminated
from the traces at 4 µs sampling time and 10 kHz hardware filter. The time distributions
rather resemble gamma functions instead of exponential functions and the peak values are
far from zero, which is what is expected from translocation experiments. This is
consistent with the exponential description since the gamma function is mathematically
reducible to an exponential, for which the mean value is the relaxation time. However, no
current translocation model provides mechanistic insights to justify such a distribution.
Analysis of the transient events recorded at different voltages is a helpful tool for
data interpretation in terms of identifying the origin of specific electronic signatures, i.e.
putative translocations versus collisions [56, 61]. The E1 events recorded at voltages
ranging from -40 mV to -100 mV showed a linear relationship of the mean <IB>s for the
entire voltage range (Figure 6a). This is indicative of putative translocation [7] since the
currents are proportional to voltages for ohmic behaviors, i.e. the applied voltage does not
affect the conductance. The analysis of the E2 events indicated a minor influence of the
applied voltage on currents, which is characteristic to failed translocation attempts, i.e.
molecules bumping into the pore and diffusing away [7]. Both E1 and E2 events were
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characterized by a decrease of the mean tD for increases in the transmembrane voltage
(Figure 6b). However, the E2 events presented a greater influence of the applied voltage
on the dwell time, while the E1 events underwent less pronounced changes. This
observation seems inconsistent with studies showing that the applied voltage may
strongly influence the tD of putative translocations [59]. However, a recent report shows
[6] that the translocation time of short and weakly charged molecules is less influenced
by voltage, probably due to a greater contribution from diffusion. Nonetheless, diffusion
alone is not expected to overcome the significant electrostatic barrier presented by the
large electric field inside the channel and to allow diffusive-only translocation.

Figure 6.
Mean current blockages and mean dwell time as a function of the
applied voltage. a) The mean <IB> of events E1 (squares) increased linearly with the
applied voltage, suggesting putative translocation. On the other hand, E2 events
(triangles) had minimal effects in response to the applied voltage. b) The mean tD of
both E1 (squares) and E2 (triangles) events decreased with the applied voltage. (mean
± S.D, n=3). (Adapted from Shrestha et al. (2017) [53])
Investigations focused on effects of applied voltage on translocation of either
short nucleotides or peptides indicate a quasi-linear dependency of the frequency of
interactions for voltage ranges similar to what we used for our experiments [6, 21]. Our
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analysis performed on each class of events, i.e. E1 and E2, showed a similar linear
dependency (Figure 7). The number of counts per time unit varied significantly between
the three independent experiments, as indicated by the large deviations, but each one
presented the same trend. Also, we observed that the frequency varied with time and it
was greater at the end of each experiment, which we explained by considering the
accumulation of the analyte in the vicinity of the channels owing to the electrophoretic
force. Nonetheless, the slopes of the plots were relatively uniform and equal; indicating
that for each voltage in the range of the ratio between translocations and collisions was
close to unitary.
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Figure 7.
Voltage dependence of the frequency of E1 events (a) and E2 events (b)
per single nanopore. The experimental points represent mean ± SD, n = 3. (Adapted
from Shrestha et al. (2017) [53])
Liquid chromatography-mass spectroscopy analysis of angiotensin II translocation
through large populations of lysenin channels
Since the first use of α-HL for DNA translocation, PCR amplification has proven
to be very effective for detection and identification of translocated nucleic acid molecules
[1]. However, such techniques are not available for peptide amplification, and their
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detection and identification is seriously challenged by the very low amounts resulting
from translocation experiments [11, 19, 62], which are difficult to analyze by any current
methodology. To circumvent this roadblock, qRT-PCR has been used to identify
translocated chimeric DNA-peptide molecules [55]; however, the analyte was structurally
different, which raises the question if the DNA was actually the carrier of the peptide.
Similarly, addition of fluorescent tags may structurally change the molecules and strongly
affects their interactions with the channels, thus introducing undesired variables in the
experimental setup. A great advancement in this line was reported for detection,
identification, and quantitation of proteins translocated through synthetic nanopores [62].
To enable such achievement, the analyte was translocated for extended time through a
silicon nitride nanopore at large bias potentials and the assessment was performed by
using a very sensitive chemiluminescence-based approach [62]. However, the bilayer
lipid membranes are rather fragile structures, their lifetime is limited, and the application
of large transmembrane potentials leads to premature rupture owing to the large
transmembrane electric field. However, the synthetic nanopore experiments indicate that
translocated protein molecules may be detected and identified with high sensitivity
techniques if sufficient molecules are accumulated. To increase the amount of
translocated peptide, we adjusted both the number of lysenin channels inserted into the
membranes and the duration of the experiments [45, 51]. After Ang II translocation
through large populations of lysenin channels at -100 mV bias potential, samples from
the trans reservoirs have been subjected to LC-MS analysis along with a standard sample
containing 100 ng peptide. The presence of Ang II in the trans reservoir was clearly
indicated by both LC and MS (Figure 8 c,d). However, supplementary evidence was
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needed to demonstrate that the analyte passed through lysenin channels. At high
concentration, Ang II is capable of interacting with pristine artificial lipid membranes
[63, 64]. This interaction is manifested as either pore formation [63], and hence an
increased permeability, or a sustained adsorption at the membrane surface [64], which
may promote further transmembrane transport.
To eliminate any concern with regards to non-specific Ang II transport through
artificial membranes, we performed extended experiments of Ang II translocation
through large populations of lysenin channels biased by positive potentials (+100 mV).
Although lysenin channels may gate at positive voltages, high salt concentration and
congested conditions almost completely eliminate this feature, and most of the channels
will remain in the high conducting state in such experimental conditions [45, 51]. The
requirement of proper orientation of the external electric field for enabling translocation
was inferred from the absence of LC signal in the sample collected from the trans
reservoir after 36 hours of exposure to positive voltages (Figure 8e). Still, the absence of
a signal may be simply linked to the opposite electrophoretic force created by the reverse
electric field, which will prevent translocation through either open channels or membrane
permeabilized by Ang II. To further support the hypothesis of Ang II translocation only
through open channels, the next experiment employed the use of large populations of
lysenin channels in which the membrane was biased by -100 mV (to promote
translocation) but the channels were irreversibly blocked by chitosan addition as
described in the methods section and elsewhere [54]. The LC analysis of samples
collected from the trans reservoir showed the absence of Ang II (Figure 8f); while it is
still possible that spontaneous transmembrane translocation of Ang II at levels below the
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LC-MS detection limit occurred, clearly open lysenin channels inserted into the
membrane are needed to mediate peptide translocation at detectable levels.

Figure 8.
Verification of the translocation of Ang II using LC-MS after running
the experiments in the presence of large population of lysenin channels for 36 hours
at -100 mV. a) The MS of standard Ang II (100 ng) with m/z of 349.5 (z = 3+), b) LC
chromatogram of standard 100 ng Ang II, c) The translocated samples collected
from trans reservoir after application of -100 mV for 36 hours indicated the
presence of Ang II by (c) MS and (d) LC. In the similar condition, LC did not detect
Ang II on the trans solution when (e) applying +100 mv voltage, and (f) blocking the
channels with chitosan. [53]
By integrating the LC peak areas for Ang II amounts in the range 1 ng-100 ng
(Figure 9a), a standard calibration curve was constructed (Figure 9b) and used to estimate
the total amount of peptide translocated through the large population of lysenin channels
(~ 0.8 ng). By equating this amount to the total number of channels and duration, we
computed a translocation frequency of ~1,100 events/s, which is practically twice as
much as the average value estimated from single channel experiments at the same voltage
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(see Figure 7). This discrepancy may be explained by accounting for the large deviations
in the frequency data, which may originate in their time-dependency resulting from local
accumulation of the analyte in the vicinity of the channel. However, the hypothesis that
both type of events represent translocations is not consistent with the observed effects of
voltage on the current blockages and dwell times characteristic to the two distinct event
types.
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Figure 9.
The LC chromatograms of standard Ang II. a) The LC chromatograms
of known Ang II obtained from the different amount of Ang II from 1-100 ng. b) The
standard curve (triangles) obtained from the integrated area under the curve as
shown in (a) to determine the unknown concentration of Ang II (full square).
Conclusions
Lysenin channels inserted into artificial lipid membranes present a great potential
for single molecule sensing and characterization. By employing single channels and Ang
II we demonstrated that lysenin allows the translocation of un-modified peptides, and
therefore may be used for stochastic sensing using the resistive pulse technique. The large
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diameter of the channel enables analysis of molecules larger than what may be used with
other nanopores of biological origin. The absence of vestibular structures and
constrictions yields events that are easily classified as putative translocations or
collisions. No other biological nanopores provide such a clear distinction between the
two event types when peptide molecules are used as analytes. The excellent stability of
lysenin channels reconstituted in bilayer lipid membranes demonstrated that translocation
requires the molecules to be electrophoretically driven through the open channels. This is
the first proof of translocation of un-altered peptide molecules through a biological
nanopore. LC-MS allowed not only peptide identification but quantitation, which
satisfactorily matched the experimental data originating in single channel experiments.
Lysenin also presents biophysical properties that are uncommon among PFTs, such as
reversible gating or irreversible blockage. These unique regulatory mechanisms, in
conjunction with bio-engineering approaches may be used to further expand the sensing
capabilities beyond translocation and design a new class of smart biosensors and
bioactuators with applicability in early diagnosis, drug delivery, and self-control of micro
bioreactors.
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CHAPTER THREE: LYSENIN CHANNELS AS NANO-SWITCHES FOR
CONTROLLED MEMBRANE PERMEABILITY

Abstract
The functionality of cells may be modulated by numerous classes of exogenous
molecules such as nucleic acids, homing peptides, and small activators and inhibitors. In
many instances, these molecules must cross the plasma membrane to exert their
biological effect, and this is often realized by specific or non-specific transport
mechanisms employed by cells. However, the plasma membrane presents a high
selectivity, and therefore constitutes a barrier that prevents the access of extra-cellular
molecules to the cytosol. Overcoming the selective nature of the membrane enables
manipulating fundamental cellular functionalities and presents opportunities to target,
identify and investigate distinct molecules or cellular processes. To achieve this goal,
controlled access to the cytosol may be achieved by microinjection, electroporation,
optoporation, lipovesicles, and cell-penetration peptides. Each of these techniques have
limitations such as single-cell applicability, invasiveness, low efficiency, expensiveness,
tedious procedures, or the necessity of using sophisticated dedicated instruments. In
addition, biomedical and scientific applications may require transmembrane transport into
small artificial lipid vesicles, which are not easy to permeabilize by using the above
methods. To overcome many of these barriers, we propose to use lysenin for temporary
permeabilization of artificial and natural lipid membranes. Lysenin is a pore-forming
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toxin extracted from the earthworm Eisenia fetida, which inserts large conducting
channels into lipid bilayer membranes containing sphingomyelin. The large opening of
the channel is expected to accommodate the passage of relatively large molecules
significant for scientific, bio-technological and biomedical purposes. The choice of
lysenin is also motivated by the presence of unique regulatory mechanisms that employs
external physical and chemical stimuli, thereby enabling exquisite control over
membrane permeability.
The work hereby aims at demonstrating that lysenin channels may be used as
nano-switches for controlling the permeability of artificial and natural membrane
systems. Experiments employing electrophysiology explorations of ionic transport
demonstrate that ATP may reversibly control the macroscopic conductance of lysenin
channels reconstituted into planar lipid membranes. Investigations performed on
unilamellar liposomes show that non-permeant dyes may be loaded in the inner waterfilled cavity through transmembrane diffusion mediated by lysenin channels. Further
explorations demonstrate that the permeabilized membrane can be resealed by
multivalent cations that force the channels to close. In addition, cation removal by
precipitation re-opens the channels and allow the incorporated dye to leak out. Next, we
investigated the lysenin-mediated transport of cell impermeant fluorescent molecules into
two distinct cell lines, Jurkat and ATDC5, respectively. Careful selection of dead/live
fluorescent dye allowed us to assess both permeabilization efficiency and survival rate. In
addition, we successfully demonstrated that bio-inert chitosan polymer molecules can be
used to effectively turn off the lysenin-induced permeability by irreversible channel
blockage.
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Introduction
The highly regulated transport of ions and molecules across cell membranes is
paramount for fundamental cellular processes such as nutrient transport, energy
production, transmission of information, or communication [1-7]. To overcome the
natural barrier function presented by the lipid membrane, cells developed specialized
transporters capable of selective transport in response to chemical or physical stimuli.
However, assessing, controlling, or introducing novel cellular functionalities for the
purpose of cellular or molecular manipulation requires non-invasive introduction of
biologically relevant molecules into living cells, which is greatly challenged by the same
selective nature of the plasma membrane. To overcome the membrane barrier and gain
access to the cytosol, a number of techniques have been developed and employed over
the years. Microinjection is one of the most commonly used techniques but is tedious,
invasive, requires experienced personnel, and is limited to single cells [8].
Electroporation, or electrical pore formation in cell membranes under exposure to an
external electric field, is very popular for cytosol entrapment of exogenous
macromolecules, including foreign genes [9]. However, the strong external electric field
needed for efficient electroporation often leads to low efficiency by significantly
diminishing cell viability [10]. Optoporation, another non-contact method of single-cell
permeabilization, requires sophisticated instruments [11] and may suffer from undesired
interactions between the strong laser light and strong absorbers present in the exposed
cell. Lipovesicles, lipophilic carriers and cell-penetrating peptides are included with
intracellular delivery methods which are efficient in the delivery of DNA but often have
limitations presented by cargo trapping in endosomal and lysosomal vesicles [12-15]. In

62
spite of wide applicability of the above methods in science, technology, and medicine,
scientists are actively pursuing other more effective approaches for delivery of foreign
molecules into living cells while maintaining cell viability. This is justified by the
recognition that methods for controlled transport across natural and artificial membranes
hold significant potential to revolutionize the field of science, biomedicine, and
nanotechnology [16-20]. Externally controlled transport of exogeneous molecules
through lipid membranes would not only provide novel insights into the functionality of
cells and enable modulation of essential cellular functions but would provide
opportunities for localized and controlled drug delivery, or novel design of nano-vesicles
and smart bioreactors for biomolecule production.
Pore-forming proteins (PFPs) are among the most sought after gate-keepers for
initiating and controlling the transmembrane transport in artificial and natural membrane
systems. These pores provide nano-sized conducting pathways for the transport of
molecules across membranes. Streptolysin-O, a cytolytic exotoxin from streptococci,
forms large pores (up to ~30 nm diameter) in membranes containing cholesterol [21].
Owing to its large size, this toxin is able to deliver exogenous non-permeant molecules to
the cytosol, including oligonucleotides, proteins, and dyes [21-24]. An engineered αhemolysin (α-HL) from Staphylococcus aureus was designed as a metal-actuated switch
for closing and reopening using Zn2+ ions and chelating agents [20]. The incorporation of
α-HL in artificial vesicles paved the way to investigating transient and weak interactions
of biological molecules in confined nano-vesicles [25].The large conductance pore of the
bacterial mechanosensitive channel MscL (>2.5 nm diameter) was engineered in such a
way to make it responsive to light and pH, and to deliver molecules into mammalian cells
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[26-29]. In addition, MscL was embedded into an artificial system for releasing the
entrapped solvent content [30]. The E.coli porins OmpF and Tsx have been included in
the “membrane” walls of bioreactors encapsulating prodrug-activating enzymes [31]. The
small prodrugs transported inside through the porins become activated and diffuse out as
active drugs. Listeriolysin-O from Listeria monocytogenes and C2 toxin from
Clostridium botulinum have shown promising results in mediating the transport of
biologically active molecules across the membrane barrier [32-37].
All the above studies demonstrate PFP’s applicability in facilitating the transport
of otherwise non-permeant molecules across membranes. However, there are limitations
for their use as controlled transporters, such as: cumbersome isolation and purification,
difficult reconstitution in artificial or natural membrane systems, absence of high
resolution structural data, premature leakage at rest, and lack of intrinsic regulatory
mechanisms. To overcome these limitations and to develop nano-switches for controlled
permeability, we propose using lysenin channels reconstituted into artificial and natural
lipid membranes.
Why lysenin? Lysenin is a 297 amino acid PFP extracted from the coelomic fluid
of the earthworm Eisenia fetida [38-40]. Although lysenin has no determined
physiological role in the host organism, its strong cytolytic and hemolytic activity [39,
41, 42] is related to the ability to self-insert a large nonameric pore of ~ 3 nm diameter in
artificial and natural membranes containing sphingomyelin [43-50]. This large lysenin
pore provides an excellent opportunity for transporting relatively large molecules across
the membrane in which it is inserted. The lysenin channel is larger than α-HL (which is
~1.5 nm diameter) [51], hence may ensure a higher transport rate and reduced steric
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hindrance. In addition, lysenin channels possess intrinsic regulatory mechanisms that set
it apart from other pore forming toxins and open novel avenues for the development of
stimuli actuated nano-switches for controlled transport. Lysenin channels are regulated
by transmembrane voltages in the physiological range [41, 52, 53]. The voltage-induced
gating manifests as fast conformational transitions of the channel from conducting (open)
to non-conducting (closed) state at transmembrane potentials larger than ~ 20 mV [41,
52, 53], potentially enabling the use of the channels as voltage-responsive nanoswitches. Another salient regulatory feature of lysenin channels is the reversible
regulation by multivalent ions [54, 55]. Trivalent metal cations including La3+, Eu3+,
Ce3+, Tb3+, and Al3+ are very effective inhibitors and reduce the macroscopic
conductance of lysenin channels to negligible values at concentrations of ~100 µM [54,
55]. The conductance blockage mechanism is based on ligand-gating and it is reversible
since the initial conductance of each channel can be reinstated after ligand removal by
addition of chelating or precipitating agents [54, 55]. This feature adds distinct
opportunities for external control of the conducting state by using cations (i.e.,
multivalent metals) or anions (i.e., adenosine triphosphate-ATP) trapped in photolabile
cages [56]. Another important characteristic of lysenin channels is their irreversible
blockage by the positively charged polymers chitosan and polyethyleneimine [57], which
may be used to reseal the membranes by blocking the lysenin channels and shutting down
the transport.
In this study, we hypothesize that lysenin channels can be used to gain controlled
permeability over artificial and natural lipid membranes. Planar bilayer lipid membrane
(BLM) experiments were employed to study the reversible modulation of lysenin channel
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conductance by ATP, along with irreversible blockage by chitosan in complex
electrolytes. Studies performed on spherical lipid membranes (liposomes) demonstrated
that the in and out traffic of non-permeant fluorescent molecules can be reversibly
controlled by Al3+ cations and precipitating agents. Human acute T-cell leukemia Jurkat
(suspension) and mouse chondrogenic ATDC5 (adherent) cells were used as models for
investigating lysenin channels as transmembrane nanovalves for transport of nonpermeant molecules. These studies included controlled permeability assays and viability
assessments.
Materials and Methods
Preparation of planar bilayer lipid membranes
BLMs have been prepared in a custom-made chamber comprised of two ~1 ml
reservoirs made of polytetrafluoroethylene (PTFE) and separated by a thin vertical PTFE
film (~120 µM thickness, McMaster) in which a small hole (~70 µm diameter) was
produced by an electric spark. The film was sandwiched between the two reservoirs with
a thin layer of silicone grease to achieve a water-proof sealing. The bilayer was produced
by the Montal-Mueller method [58], i.e. painting the hole with a small amount (< 1 µl) of
a stock lipid mixture containing 10 mg asolectine (Aso, Sigma-Aldrich), 4 mg cholesterol
(Chol, Sigma-Aldrich) and 4 mg sphingomyelin (SM, Avanti Polar Lipids) dissolved in
200 µl of n-decane (Alfa Aesar). The electrolyte solutions were 1X Hank’s Balanced Salt
Solution (1X HBSS, Thermo Fisher), or 135 mM KCl containing 20 mM HEPES, pH
7.2. Electrical connections to the headstage of the recording device (Axopatch 200B
electrophysiology amplifier, Molecular Devices) have been provided by Ag/AgCl
electrodes embedded in the solutions (Figure 1).
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Figure 1.
Simplified diagram (not to scale) of the experimental setup for studies
employing bilayer lipid membranes. A planar lipid membrane created in a hole
produced in a thin PTFE film serves as support for the insertion of lysenin channels.
Two Ag/AgCl electrodes inserted into the electrolyte solutions bathing the membrane
ensure electrical connections to the recording device. Optionally, the electrodes may
be connected to the solutions via salt bridges. All BLM experiments were run in
voltage-clamp mode.
The analog signal provided by the amplifier was fed into a DigiData 1440A
digitizer (Molecular Devices) connected to a PC for real-time visualization and recording
with the Clampex 10 software package (Molecular Devices). The formation of the
membrane was monitored by indirectly estimating the membrane capacitance from the
capacitive current measured in response to a triangle-shaped voltage stimulus and the
integrity of the membrane was estimated from the leakage current measured in response
to a DC voltage stimulus (100 mV). A “good” membrane was characterized by a
capacitance of ~ 65 pF and a leakage current no greater than 0.1 pA, which corresponds
to a seal resistance of at least 1000 GΩ. After a stable membrane was achieved, channel
insertion was performed by adding lysenin to the ground reservoir under continuous
stirring with a low noise Bilayer Magnetic Stirrer (Warner Instruments) at room
temperature. The channel insertion process was monitored from the changes in the ionic
current through the membrane biased by -60 mV [52, 53]. The completion of insertion
was indicated by a steady value of the macroscopic ionic current; when this was
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achieved, the un-inserted lysenin was removed from the bulk by buffer exchange with a
lysenin-free electrolyte solution. ATP (Sigma-Aldrich) was prepared as 1 M stock
solution by dissolving the powder in pure water. A stock chitosan solution was prepared
by dissolving the chitosan (average Mw 200,000, Across Organics) in 0.1 M acetic acid at
a final concentration of 1% (w/v). Propidium iodide (PI) and ethidium homodimer-1
(EtHD, Thermo Fisher) were prepared by solvation in 135 mM KCl at a final
concentration of 1 mg/ml, and 2 mg/ml, respectively.
Preparation of liposomes
Liposomes were prepared by the extrusion method [59]. Chloroform solutions of
8 mg Aso, 2.5 mg SM, and 2.5 mg Chol were vacuum-dried overnight in a glass vial and
the resulting lipid cake was slowly hydrated at 65oC for five hours in 1 ml solution
containing 135 mM KCl and 20 mM HEPES (pH 7.2). After each hour, the mixture was
subjected to a freeze-thaw cycle by placing it in the freezer for twenty minutes, and
immediately followed by immersion of the vial in hot water. Large aggregates visually
observed in the solution after hydration were fragmented by short sonication (<10
seconds) in a benchtop sonicator. After the completion of hydration, the lipid solution
containing multilamellar liposomes was extruded 40 times through stacked polycarbonate
filters (1 µm pore diameter, Whatman) mounted in a Mini-Extruder (Avanti Polar Lipids)
placed on a hotplate and kept at constant temperature (65oC) for the entire duration of
extrusion. After extrusion, the liposome solution was collected from the syringe, cooled
down at room temperature and stored in refrigerator for further experiments. Image
analysis was performed with a Nikon TS100 microscope equipped with an Infinity
camera (Lumenera) and Nikon filter sets suitable for calcein. A stock solution of calcein
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(50 µM) was prepared by dissolving it in 135 mM KCl, 20mM HEPES, pH 7.2. Calcein
fluorescence quenching by multivalent ions (Al3+, prepared as 10 mM solution in water
from a 2 M AlCl3 stock solution) was analyzed by using a Fluoromax 4P fluorometer
(Horiba) set in emission mode (λex = 485 nm, λem = 490nm - 550nm). The fluorescence
spectrum of 50 µM calcein solution was recorded before and after successive addition of
AlCl3 solution to the sample in the cuvette under continuous stirring. The quenching
curve was plotted as relative fluorescence intensity at 520 nm versus [Al3+]. Al3+ removal
was performed by precipitation with small amounts of a 2 M sodium phosphate solution
made by mixing the monobasic dihydrogen phosphate and dibasic monohydrogen
phosphate forms.
Cell-permeabilization experiments
To demonstrate lysenin’s capabilities to control cell membrane permeability via
pore formation, we utilized Jurkat and ATDC5 cell lines.
Jurkat cells (American Type Culture Collection), kindly provided by Dr. Denise
Wingett at Boise State University, were grown in RPMI-1640 media (Sigma-Aldrich)
supplemented with 10% fetal bovine serum (FBS, Atlanta Biologica), 1%
penicillin/streptomycin, 1.5 g/L sodium bicarbonate, 4.5 g/L D-(+) glucose, 10 mM
HEPES, 1 mM sodium pyruvate, and 2 mM L-glutamine. Cells were grown at 37oC and
5% CO2, and passaged before reaching a cell density of ~1 x 106 cells/ml. On the day of
experimentation, cells were counted using a bright-line hemocytometer (Hausser
Scientific), washed twice with 1 ml of modified 1X HBSS (without calcium chloride,
magnesium sulfate, sodium bicarbonate or phenol red, Sigma-Aldrich), centrifuged, and
the cell-pellet was resuspended in 1X HBSS containing 1 µg/ml PI. One hundred µl
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solution, containing ~1 x 105 cells were seeded per well in tissue culture treated 96 wells
plate (Corning). Two sets of four wells with cells (one set for permeabilization only, and
the other for chitosan blockage) underwent addition of 1 µl of 0.6 mg/ml lysenin per well.
No lysenin or chitosan was added to another set of four wells included as a control in the
experiment. A Biotek Synergy MX microplate reader (BioTek) was used to measure the
fluorescence intensity of PI every 5 minutes for 50 minutes total duration. The
measurement from all samples was taken at excitation/emission wavelength of 535/617
nm and sensitivity set at 65 at room temperature. After 20 minutes, 0.5 µl of 0.1%
chitosan in 0.01 M acetic acid (25 nM final concentration) was added to one set of four
wells to assess the inhibition of PI transport through lysenin channels upon blockage with
chitosan.
Jurkat cell viability. In a first set of experiments, we investigated the doseviability relationship for Jurkat cells exposed to either lysenin or chitosan by using the
Alamar Blue (resazurin) assay [60]. Jurkat cells were resuspended in either modified 1X
HBSS or complete Jurkat medium (89% RPMI-1640 medium, 2 mM L-glutamine, 10
mM HEPES, 1 mM sodium pyruvate, 4.5 g/l D-(+)-glucose, 1.5 g/l sodium bicarbonate,
10% FBS, and 1% penicillin/streptomycin) at ~5 x 105 cells/ml and 0.2 ml of the cell
suspension was seeded into flat-bottom 96 well plates. The cells were rested at 37 °C and
5% CO2 for 30 minutes, then treated in the same conditions with either lysenin (0 – 500
nM) for 30 minutes, or chitosan (0 – 250 nM) for 20 hours. Resazurin solution (10% (v/v)
was added to each sample for an additional 4 hour incubation period at 37 °C and 5%
CO2. The reduction of the blue, non-fluorescent resazurin to fluorescent resorufin in
viable cells was measured by using the Biotek Synergy MX microplate reader at 530 nm
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(excitation) /590 nm (emission). The percent viability for each treatment was calculated
as percentage of untreated controls.
ATDC5 cells, kindly provided by the Biomolecular Research Center at Boise
State University, were grown in GIBCO® Dulbecco’s modified Eagle’s medium: nutrient
mixture F -12 (DMEM/F12) supplemented with 5% FBS and 1% penicillin/streptomycin.
Cells were grown until they reached a confluency of 70-80%, after which they were
trypsinized for 7-9 minutes with 0.25% trypsin-EDTA. The enzyme was deactivated by
the addition of 7 ml of medium. The cells were counted using the hemocytometer,
centrifuged, and resuspended in fresh media before seeding in a tissue culture-treated 75
cm2 flask (VWR International) at cell densities of either ~1 x 105 cells/ml or ~0.5 x 105
cells/ml. The cells were grown and maintained at 37oC and 5% CO2.
For ATDC5 cell permeabilization experiments, two ml of ~1 x 105 cells/ml were
seeded in 35 mm glass bottom culture dishes (GBCD) with 10 mm microwell (MatTek
Co). Cells were incubated at 37oC and 5% CO2 for ~24 hours. ATDC5 cell membrane
permeabilization via lysenin channels was imaged and assessed by using a Zeiss LSM
510 Meta confocal system with the Zeiss Axiovert Observer Z2 inverted microscope and
ZEN 2009 imaging software (Carl Zeiss, Inc., Thornwood, NY). Images were acquired in
a single plane utilizing the Plan-Apochromat 20x/NA 0.80 or Fluar 40x/NA1.30 oil
objectives and with Argon (488 nm) and HeNe (543 nm) laser sources. Fluorescence was
detected using a 500 – 550 nm band-pass for calcein and a 590 long-pass filter for
PI/Alexa 546-phalloidin (Thermo Fisher), respectively.
On the day of experimentation, one day-old cell cultures in GBCD were washed
twice with 1 ml of modified 1X HBSS, followed by addition of 200 µl of 2 µM calcein-
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AM (Thermo Fisher) to estimate cell-viability. Permeabilization was monitored upon
simultaneous addition of 100 µl of 1 µg/mL of PI solution containing 1 µl of 0.17 µg/µl
of lysenin monomer.
To determine the loading of cell-impermeant phalloidin conjugated with Alexa546, cells were washed twice with 1 ml of 1X HBSS followed by the addition 100 µl of
1X HBSS to each microwell. One µl of 0.6 µg/µl lysenin was added to the cell solutions
and incubated for ~10 minutes at room temperature. Cells were washed twice with 1 ml
of 1X HBSS to remove the free lysenin from the bulk solution, and 100 µl of Alexa
Fluor® 546 Phalloidin working solution added for permeabilization imaging by confocal
microscopy. A stock solution of Alexa Fluor® 546 Phalloidin was prepared by dissolving
300 units in 1.5 ml pure methanol. The working solution was prepared by diluting the 50
µl of stock solution in 1 ml of 1X HBSS.
ATDC5 cell viability. To investigate the combined influence of dyes, blockers,
and lysenin on the viability of ATDC5 cells, we based our approach on the widely-used
PI/calcein-AM double staining assay. However, we accounted for the fact that nonpermeant dyes may gain access to the cytosol upon membrane permeabilization by
lysenin. Cell preparation experiments similar to the permeabilization studies (vide supra)
were employed for viability assessment in the presence of phalloidin. The cells were
exposed to the non-permeant dye by addition of 100 µl of Alexa Fluor® 546 phalloidin
working solution and permeabilized with 1 µl of 0.6 µg/µl lysenin. After 10 minutes
incubation, the free lysenin and phalloidin were removed by washing twice with 1X
HBSS. The media in the wells was completed by addition of 2 ml DMEM/F12. After 5
hours of incubation at 37oC and 5% CO2 the cells were washed, rendered fluorescent by
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addition of 100 µl of 2 µM calcein-AM, and imaged by confocal microscopy for
combined permeabilization/viability assessments.
Results and Discussion
Controlled permeabilization of planar bilayer lipid membranes
The conductance state of lysenin channels inserted into membranes is greatly
dependent on the influences exerted by chemical and physical stimuli such as
transmembrane voltage, ligands, temperature, or blockers [41, 52-55, 57]. The objective
of gaining acquired control over the membrane permeability via conductance modulation
requires careful selection of the chemicals used as conductance controllers to minimize
undesired interferences with the membrane system under consideration. The reversible
blockage of lysenin channels by a ligand-gating mechanism triggered by multivalent ions
is well documented [54, 55]. Trivalent lanthanide cations along with Al3+ ions are the
most effective inhibitors of the macroscopic conductance of lysenin channels [54, 55]. In
addition, the conductance properties of the membrane are fully reinstated (i.e, the
channels re-open) after inhibitor removal by chelation or precipitation [54, 55]. The use
of multivalent ions may be appropriate for reversibly controlling the transport in artificial
membrane systems, and studies presented later in this thesis support this assertion.
However, some multivalent ions may induce toxicity upon interacting with living systems
[61, 62]. Therefore, we explored alternative approaches for controlling the membrane
permeability, and tested potential interferences between the channels and the various
biochemical/biological components introduced in the experimental system. Initial
experiments focused on exploring lysenin conductance modulation by ATP in artificial
membrane systems since ATP may be released from photolabile cages [56]. Exposure of
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planar lipid membranes containing lysenin channels to increasing amounts of ATP
showed a concentration-dependent inhibition of the macroscopic conductance [63]
(Figure 2a). The changes were completely reversible as indicated by conductance
recovery upon ATP removal by buffer exchange (Figure 2b).
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Figure 2.
ATP reversibly inhibits the macroscopic conductance of lysenin
channels. a) Successive addition of 1 mM ATP (as shown by arrows) to the solutions
bathing the membrane induced a concentration-dependent inhibition of the ionic
currents. b) The ionic current through the lysenin channels rapidly decreased by ~80
% upon addition of 20 mM ATP, and quickly reinstated after buffer exchange. Both
experiments were recorded at -60 mV transmembrane potential in 135 mM KCl, 20
mM HEPES, pH 7.2. (With permission of Springer, Byrant et al. (2016) [63])
These results, while encouraging, suggest that the use of ATP as reversible
channel blocker in either artificial or natural membrane systems is not an optimal choice.
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The amount of ATP needed to induce a significant decrease in lysenin-induced
permeability is relatively large. In addition, even for the highest ATP concentration used
in our studies, 20 mM, the macroscopic conductance decreased by less than 80%,
indicative of an incomplete resealing of the membrane. A leaky membrane may
contribute to rapid dissipation of the electrochemical gradient, leading to cell death. Also,
living cells are continuously producing ATP; although the average intracellular ATP
concentrations (in the low mM range) [64], are under the levels required for a significant
reduction in conductance, uncontrolled changes in its concentration may diminish the
ability to precisely control membrane permeability by affecting lysenin’s conducting
state. Therefore, our subsequent studies considered irreversible blockage of lysenin
channels by chitosan. Chitosan is a poly-cationic and bio-inert molecule that acts as an
efficient blocker of lysenin channel conductance purportedly by a trap and lock
mechanism [57]. However, earlier experiments were performed in planar BLMs bathed
by simple electrolyte solutions containing only KCl and buffer [57], and our preliminary
experiments employing live cells indicated that simple formulations are not compatible
with cell survival even for limited time exposures. Exposure of live cells to 1X HBSS, for
a short time, improved cell survival, but no study describes chitosan inhibition efficacy in
complex buffers to our knowledge. Consequently, we performed macroscopic
conductance measurements on lysenin channels inserted into planar BLMs using 1X
HBSS as the support electrolyte. Addition of 5 µl of 0.1% chitosan to the support
electrolyte (25 nM final concentration) under continuous stirring and at -60 mV bias
potential induced a rapid and significant decrease (larger than 99%) of the macroscopic
ionic current, confirming that channel blockage may occur in this particular electrolyte
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solution (Figure 3). Buffer exchange did not reinstate the macroscopic conductance, and
we concluded that the induced changes were irreversible, as previously reported for
simpler electrolyte solutions [57].
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Figure 3.
Chitosan inhibits the transport properties of lysenin channels in
complex buffers. Addition of 25 nM chitosan yielded a complete reduction of the ionic
currents at -60 mV bias potential in 1X HBSS.
Next, we asked whether the fluorescent dyes intended for analysis of membrane
permeabilization would interact with lysenin channels and modulate their conductance.
Many dual color dye pairs for assessing cell permeabilization and status (i.e., live/dead)
use non-permeant intercalating dyes, which undergo increases in fluorescence after
binding to nucleic acids [65-68], and permeant AM dyes (ester forms), which become
fluorescent after hydrolytic attack from esterases present in the cytoplasm of living cells.
Our first attempt to introduce the intercalating EtHD dye into Jurkat cells failed (no
significant nuclear staining occurred), suggesting that lysenin may not support transport
of this dye into cytosol. In order to decipher the molecular basis of this phenomenon, we
performed voltage clamp experiments by employing lysenin channels inserted into planar
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BLMs and exposed to KCl-based electrolyte solutions. Successive additions of EtHD
(final concentration 1.63 µM, and 6.29 µM, respectively) yielded an almost complete
annihilation of the macroscopic conductance, as indicated by the sustained decrease of
the ionic current at -60 mV bias potential (Figure 4a). Such dramatic influence of EtHD
on lysenin’s conductance may explain the observed inability of the dye to cross the
membrane of live cells permeabilized with lysenin, thus preventing access to the nucleus.
The mechanism of channel blockage by EtHD is unknown but based on our previous
work on lysenin inhibition we assume that electrostatic interactions are responsible for
either channel occlusion or that EtHD acts by triggering a ligand-gating mechanism [54,
55].
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Figure 4.
Lysenin channel conductance modulation by intercalating agents. a)
EtHD reduced the macroscopic ionic currents through lysenin channels b) PI addition
elicited negligible changes in the macroscopic currents. Both experiments were
performed in 135 mM KCl, 20 mM HEPES, pH 7.2, and at -60 mV transmembrane
voltage. The additions and final concentrations of the intercalating agents are
indicated by arrows.
Whatever the origin of the observed blockage, EtHD was not considered suitable
for controlled permeabilization studies. In contrast, addition of similar amounts of PI
produced only negligible changes in the ionic current (Figure 4b), suggesting the absence
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of specific or non-specific interactions with the channels. Like EtHD, PI acts as a nonpermeant intercalating agent, and is often used in combination with other AM dyes for
transport and cell status (live/dead) assessment [69, 70]. PI is also one of the most used
dyes for studies on transport through transient pores generated with laser pulses during
optoporation [71-73], and PI may cross membranes through pores larger than 1.5 nm
[74]. Consequently, we concluded that PI is the optimal choice for further studies on cell
membrane permeabilization with lysenin channels. All the other dyes used in this work
are: calcein, calcein-AM, and phalloidin, showed no changes in microscopic conductance
of lysenin channels when added to the bulk solutions at concentrations similar to what
was used for live cell experiments (data not shown).
Liposome loading via lysenin channels
To demonstrate that lysenin channels may facilitate the entrapment and release of
non-permeant molecules we conducted experiments using liposomes. Multivalent ions
were used to control the channel conducting state of lysenin, and therefore the membrane
permeability. Non-permeant calcein was used as a model molecule to assess loading into,
and release from, liposomes by fluorescence spectroscopy or microscopy. Also, given
their ability to quickly and reversibly shut down lysenin’s conductance by a ligand-gating
mechanism [54, 55], Al3+ cations were utilized in these experiments. It is worthy to note
that this approach provided an opportunity to simplify the procedure of assessing lyseninmediated loading. While unincorporated calcein may be removed by classic separation
techniques such as dialysis, chromatography, or centrifugation, we used a distinctive
property of calcein, i.e. the fluorescence quenching by multivalent metal ions [75]. This
property enabled the elimination of external fluorescence to render the loaded liposomes
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fluorescent against the background. While a previous report shows that Al3+ is among the
most potent multivalent ion for inhibition of the macroscopic conductance of lysenin, no
consistent report have determined the quenching effects of Al3+ on calcein. Our
exploration indicates that the addition of Al3+ cations to a 50 µM calcein solution
strongly quenched the fluorescence in a concentration-dependent manner (Figure 5). In
addition, fluorescence quenching occurred at concentrations larger than what is needed to
efficiently inhibit the macroscopic conductance of lysenin channels (which is ~ 25 µM
[54, 55]. The present work exploited this feature to reduce the background fluorescence
by adding quenching multivalent cations to the liposome mixture, assuming that these
ions would rapidly close the channels and quench only the unincorporated calcein. Once
resealed, it was anticipated that the sealed membrane would protect the entrapped dye
from quenching.
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Figure 5.
Al3+ effectively quenches the fluorescence of calcein in a concentrationdependent manner. Successive addition of Al3+ ions induced a progressive decrease
of the relative fluorescence of 50 µM calcein (λex = 485 nm, λem = 520 nm).

79
Wide-field microscopy indicated the presence of uniform and well dispersed
liposomes in the sample solution after extrusion (Figure 6). Spherical membrane
permeabilization was performed by vigorously mixing 50 µl liposomes with 1 µl of 0.3
µM lysenin at room temperature. Microscopy imaging performed on the sample after
permeabilization provided images similar as Figure 6 and indicated the absence of
aggregation.

Figure 6.
Well dispersed and uniform liposomes produced by extrusion.
Liposomes solution produced from lipid mixtures of Aso, Chol, and SM lipid mixtures
yield uniformly distributed and well dispersed liposomes.
After addition of calcein (50 µM final concentrations) to the solution containing
permeabilized liposomes, the sample was left to equilibrate for six hours at room
temperature in a dark container, and then microscopy images were taken. Nonfluorescence imaging showed intact liposomes in solution (Figure 7a). The lack of
fluorescence from the individual liposomes demonstrated that the fluorescent dye did not
accumulate at the membrane surface or into the intra-membrane space (Figure 7b).
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Figure 7.
Liposomes treated with lysenin and calcein are uniform and well
dispersed. a) Transmitted light imaging showing intact liposomes in solution after
permeabilization and calcein addition. b) No fluorescent liposomes have been
observed after calcein addition to the solution of liposomes containing open lysenin
channels in the membrane.
The liposome membranes were resealed by addition of 100 µM Al3+ to the
mixture, which blocked the transport through the lysenin channels, trapped the calcein
inside liposomes, and quenched the non-loaded dye. Fluorescence microscopy images
taken one hour after addition of Al3+ (50 µM final concentration) revealed highlyfluorescent liposomes and indicated their successful loading and resealing (Figure 8a).
We observed that not all the liposomes incorporated the dye by switching the
illumination from fluorescence to visible-transmitted light conditions. Although such
effect could be a result of incomplete resealing upon Al3+addition, the most reasonable
explanation relies on the fact that not all of the large liposomes produced by extrusion
were unilamellar. Lysenin may interact with multilamellar structures, but it cannot be
assumed that the inserted pores will completely penetrate thick multilayered structures to
create a conducting pathway between the inner water-filled cavity and the external
solution. Next, the release of the incorporated calcein was performed by precipitating the
Al3+ cations with 10 mM phosphate added directly to the liposome solution. A
fluorescence image taken 20 minutes after precipitation showed no fluorescent liposomes
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(Figure 8b). However, transmitted-light imaging showed intact liposomes like those
shown in Figure 7a, confirming dye leakage through the lysenin channels that reopened
after phosphate-removal of the inhibiting Al3+ cations.
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Figure 8.
Al3+ ions control the lysenin-induced permeability in liposome
membranes. a) Addition of Al3+ blocked the lysenin’s conductance, trapped the
calcein inside, quenched the non-entrapped calcein and rendered the liposomes
fluorescent against the background. b) Addition of 10 mM phosphate buffer yielded
Al3+precipitation, channel reopening, and a homogeneous distribution of the dye
inside and outside of liposomes. The liposomes were not anymore observed as
individual fluorescent structures.
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Cell-permeabilization of Jurkat and ATDC5 via lysenin channels
Viability of Jurkat cells after treatment with lysenin or chitosan. The overall
goal of a versatile and efficient approach for gaining temporary control over cell
membrane permeability, while maintaining overall viability, raises the question whether
lysenin or blockers, such as chitosan, may induce cell death at concentrations required for
membrane permeabilization or reseal. To address this question we employed viability
tests on Jurkat cells in the presence of variable concentrations of either lysenin or
chitosan. The Alamar Blue (resazurin) assay test showed that Jurkat cell viability
decreases with the concentration of lysenin in the 0 – 500 nm range (Figure 9). This
experiment demonstrates the lethal effects of lysenin on Jurkat cells, which is expected
since lysenin introduces large conducting pathways that may disperse the electrochemical
gradient and lead to cell death. Nonetheless, the maximum concentration of lysenin used
in the viability study (500 nM) is a few times greater than the concentration used for
permeabilization studies, which is ~180 nM. Although Jurkat cell viability systematically
decreased with concentration, a viability rate of ~20% was estimated even for the highest
lysenin concentration, 500 nM. This result indicates that lysenin may be used for
permeabilization while preserving viability within reasonable rates for transfection
experiments [76, 77]. The next experiment addressed Jurkat cells viability upon exposure
to chitosan. The viability data (Figure 10) showed that chitosan has negligible effects on
cell survival using concentrations one order of magnitude higher than what is required to
efficiently block the lysenin channels, i.e 25 nM in artificial membrane systems (see
Figure 3).
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Figure 9.
Lysenin affects Jurkat cell viability in a concentration dependent
manner. Cell viability decreases with lysenin concentration in the range 0-500 nM. (N
= 1-2)
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Figure 10.
Chitosan has limited effects on Jurkat cell viability. Cell-viability
measured 20 hours after incubation at different concentrations of chitosan (0 – 250
nM) demonstrated no significant effect on cell-viability until 250 nM. The highest
chitosan concentration used (250 nM) yielded a ~20% decrease in viability. (mean ±
SD, n = 3)
Chitosan control of the transport of membrane impermeant PI into Jurkat cells
PI’s fluorescence undergoes a large hyperchromic shift upon intercalation
between the stacked bases of DNA molecules, which may be used as indicator of the dye
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transport through the cell membrane. However, the membrane of living cells constitutes a
natural barrier that prevents PI crossing. Therefore, in live Jurkat cells, the PI may cross
the membrane only if the transport is mediated by transporters (such as lysenin channels)
present in the membranes. Our viability data have shown that neither lysenin nor chitosan
significantly affects Jurkat cell viability at the concentrations required by
permeabilization experiments. However, a demonstration of chitosan’s ability to
effectively control the transmembrane transport is needed. To fill this gap, we used Jurkat
cells permeabilized with lysenin in the presence of PI and analyzed the evolution of
nuclear staining in the absence of chitosan at specified times after lysenin addition. As
shown in Figure 11, the absence of lysenin from the control samples (-lysenin, -chitosan,
+ PI) elicited a steady low fluorescence, indicating that the dye did not cross the
membrane of live cells. In contrast, in the presence of lysenin, PI diffused into the cytosol
and stained DNA in the nucleus, which was observed as a gradual increase in the
fluorescence intensity. Similarly increasing fluorescence was observed before chitosan
addition in the samples intended for assessing controlled permeability by chitosan.
Nonetheless, chitosan addition at 20 minutes prevented further diffusion of the dye (as
observed from the steady fluorescence), confirming that the transmembrane transport of
PI was stopped. The increase in fluorescence observed for the first point recorded after
chitosan addition may be explained by the PI still present in the cytosol but not yet
diffused into the nucleus. These studies support the conclusion that chitosan addition
prevented further PI transport by blocking the lysenin channels.
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Figure 11.
Chitosan is effective in controlling the transport of PI across the cell
membrane in Jurkat cells. PI entrance via lysenin channels was assessed from the PI
fluorescent intensity. Addition of chitosan 20 minutes after the initiation of
permeabilization stabilized the fluorescent intensity (triangles). In contrast, continual
increase of fluorescence was measured for the unblocked lysenin channels (circles).
In the absence of lysenin, PI did not cross the cell membrane (squares). The steady
line obtained in the absence of lysenin is indicative of membrane integrity. (mean ±
SE, n = 4)
ATDC5 cells permeability and viability
To simultaneously assess the efficiency of lysenin-induced permeabilization and
cell viability we employed the live/dead staining technique comprising the use of calceinAM/PI pair. Calcein-AM has a weak fluorescence signal in the ester form but its
lipophilic character renders it membrane-permeant. In the cytoplasm of living cells, the
dye is converted to the highly fluorescent calcein form by the hydrolytic activity of active
esterases, therefore cell viability is indicated by sustained green fluorescence. In contrast,
PI is non-permeant through the membranes of viable cells, but it may pass through
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membranes with impaired transport (i.e, dead cells or permeabilized membranes).
However, both dyes may cross the membrane through lysenin channels inserted into
viable cells membrane, and this feature was used for simultaneous analysis of
permeability and viability. The viability of untreated ATDC5 cells was estimated by
confocal microscopy in the presence of calcein-AM (Figure 12a). A succession of images
taken at different time intervals after membrane permeabilization by lysenin in the
presence of PI (Figure12, b-f) showed the development of a red color that increased with
time. This evolution may be explained by the passage of PI through lysenin channels and
further staining of the nucleus. However, the green fluorescence persisted, suggesting that
many cells maintained viability. As time elapsed, some red-stained cells presented
reduced or no green fluorescence, which was considered indicative either of cell death
due to prolonged exposure to lysenin or excess of loaded PI.
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Figure 12.
Lysenin is able to permeabilize adherent ATDC5 cells and allow PI
uptake. Time evolution of PI uptake into ATDC5 cells permeabilized with lysenin
channels. The cells were simultaneously stained with permeant calcein-AM (green
fluorescence) and non-permeant PI (red fluorescence). Scale bars: 50 µm
Transport of cell-impermeant phallodin in ATDC5 via lysenin channels
Our explorations on lysenin-induced permeabilization in ATDC5 cells continued
by investigating the mediated transport of phalloidin, a bicyclic heptapeptide toxin from
the poisonous mushroom Amanita phalloides [78]. With the well-known exception of
hepatocytes, which readily take it up through an unknown mechanism, phalloidin is
membrane non-permeant. Once transported into the cytosol, phalloidin binds to
filamentous-actin (F-actin) with high affinity, thereby preventing the depolymerization of
actin fibers [79-82]. The specific tagging of phalloidin with dyes that fluoresce only upon
binding to F-actin evolved into powerful methods of actin filaments investigations [8386]. However, these procedures require access to the cytosol, which may be achieved by
microinjection, optoporation, or transfection [11, 29, 87]. To simplify the experimental
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approach, we propose the use of lysenin for introducing cell-impermeant phalloidin into
adherent ATDC5 cells. Cells grown in 35 mm culture dishes for 24 hours, incubated with
lysenin for ~ 8-10 minutes, and subsequently washed, have been exposed to Alexa-546®
phalloidin conjugate. An otherwise similar control experiment comprised the addition of
Alexa-546® phalloidin conjugate without the intermediate step of lysenin-induced
permeabilization. After cell identification in the well by transmitted light microscopy
(Figure 13a), confocal microscopy analysis showed that the lysenin-treated samples
developed the characteristic red fluorescence, hence confirming phalloidin passage
through the membrane and F-actin attachment (Figure 13b). In contrast, the control
sample containing phalloidin treated cells that were not previously exposed to lysenin
showed no characteristic red fluorescence (See Figure 14b), confirming that phalloidin is
able to cross the membrane barrier only through open lysenin channels.
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Figure 13.
Lysenin channels allow the transport of membrane-impermeant
phalloidin across the cell-membrane. a) The transmitted light image showing the
presence of cells and (b) the fluorescence image showing the presence of intracellular
phalloidin after lysenin treatment. Scale bars: 20 µm
ATDC5 cell viability after loading phalloidin via lysenin channels. Lysenin is
a cytolytic pore forming toxin and phalloidin may exert toxicity effects by inhibiting the
depolymerizaton of F-actin, hence their conjugate actions may affect cell viability. To
examine the potential combined lethal effects, we used calcein-AM as a live indicator in
conjunction with Alexa Fluor 546 phalloidin as permeability tracer for lysenin
permeabilized, and non-permeabilized (control) ATDC5 cells. The cells incubated with
lysenin and Alexa Fluor 546 phalloidin for ~ 10 minutes and analyzed by confocal
microscopy showed bright red staining of actin filaments, indicative of permeabilization
(Figure 14 a (i)). However, the negative control cells (-lysenin, + Alexa Fluor 546
phalloidin) did not show the characteristic red fluorescence in otherwise identical
conditions, demonstrating that untreated membranes do not allow phalloidin passage
(Figure 14 b (i)). Next, lysenin-exposed cells and control cells were incubated in
DMEM/F12 for ~ 5 hours, and calcein-AM added for viability assessments. Both lysenin-
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permeabilized and non-permeabilized ATDC5 cells showed the green fluorescence,
indicative of live cells at this time point. (Figures 14 a (ii) and b (ii)).
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Figure 14.
The phalloidin loaded, lysenin-permeabilized ATDC5 cells remain
viable after 5 hours. a) Lysenin-permeabilized cells allowed (i) phalloidin loading , (ii)
and calcein-AM fluorescence indicated cell-viability after incubation in DMEM/F12
media for 5 hours. b) The lysenin-free control showed (i) the absence of phalloidin,
while (ii) calcein-AM fluorescence indicated cell-viability in otherwise similar
conditions.
Conclusions and Perspectives
Our studies provide evidence that lysenin channels may be used to gain control
over the permeability function of artificial and natural cell membranes. The employment
of liposomes as model lipid membranes allowed reversible control of molecular transport
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through lysenin channels using Al3+ cations as inhibitors of conductance. In addition,
cation removal by precipitation reinstated the macroscopic conductance and high
membrane permeability. Two distinct cell lines, Jurkat and ATDC5, respectively, were
employed for lysenin-mediated permeabilization studies, in conjunction with viability
assessments. Successful loading of macromolecules such as dyes and bicyclic peptides
through lysenin channels inserted into membranes, while maintaining cell viability,
supports the applicability of this approach to temporary cell membrane permeabilization.
Lysenin’s pore-formation mechanism requires the presence of SM in the target
membrane, which could be considered a limiting factor for wide applicability. However,
SM may be easily introduced in artificial membrane systems, and SM is also a major
component of all mammalian cells, therefore numerous biological systems may be
explored. Lysenin has also the unique advantage of responding to multiple regulatory
mechanisms, which enhance the control of membrane permeability. Our work on
liposomes showed that multivalent cations may be used to gain advanced control over the
membrane barrier function. While such advanced capabilities are critical for artificial
membrane systems, their utility for live cells is not conclusive because of their potential
cytotoxicity. Controlled permeability studies performed on Jurkat cells demonstrated that
chitosan may be used to control the passage of PI. In addition, viability tests of this cell
line showed that lysenin is not as toxic as presumed from its great cytolytic activity. In
addition, our ATDC5 studies demonstrated passage of macromolecules through lysenin
channels even in complex environments. These studies included viability tests and were
developed without employing any control of the lysenin-induced permeability. Our
results do not indicate that there was potential gating or occlusion induced by specific
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components in the bulk media. An explanation for this may be that the cells used in our
experiments are capable of sustaining multiple membrane lesions without facing
premature death. Similar explanations have been advanced for streptolysin, a potent pore
forming toxin proposed to be used for cell permeabilization, for which no regulatory
mechanism is known [88, 89]. However, regulatory mechanisms are important, as the
ability to switch on/off membrane permeability may prove crucial for cells which are
highly sensitive to electrochemical gradients, such as muscle or nerve cells. In
conclusion, our studies open novel avenues for controlling the permeability of artificial
and natural cell membranes, which may find applicability in controlling crucial biological
functionalities, development of smart bioreactors encased in lipid vesicles for enzymatic
reaction, advanced systems for controlled drug delivery, or the development of artificial
cells.
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